4
Changes in Ownership
IRulya Therapeutics Inc. Filed Acc 0001415889-24-021869
CHIEF BUSINESS OFFICER AND COO bought 38,924 shares at an average $0.62 ($24,166)
From the SEC's structured data for this filing
Trades in this filing
Table I: Non-derivative
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-19 | Purchase | +2,155 | $0.58 | $1,250 | 259,771 | D: show line 1 in the form |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-20 | Purchase | +2,500 | $0.61 | $1,525 | 262,271 | D: show line 2 in the form |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-20 | Purchase | +3,424 | $0.60 | $2,054 | 265,695 | D: show line 3 in the form |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-21 | Purchase | +2,280 | $0.61 | $1,391 | 267,975 | D: show line 4 in the form |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-21 | Purchase | +5,000 | $0.62 | $3,100 | 272,975 | D: show line 5 in the form |
| Hannah Brendan CHIEF BUSINESS OFFICER AND COO | 2024-08-21 | Purchase | +23,565 | $0.63 | $14,846 | 296,540 | D: show line 6 in the form |
| Open-market purchases · 38,924 sh · avg $0.62 · $24,166 | |||||||
Loading xslF345X05/form4-08212024_100803.xml…